Recent Updates
Recently added Catalysts
ARGX Positive Sentiment Score: 70/100

argenx to Present at TD Cowen 45th Annual Healthcare Conference

Key Takeaway: argenx has announced its participation in the TD Cowen 45th Annual Healthcare Conference, where CEO Tim Van Hauwermeiren will present on March 3, 2025. This event underscores the company's ongoing commitment to addressing severe autoimmune diseases. Interested parties can access a live webcast of the presentation through the company's investor website, with a replay option available for 30 days post-event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Tim Van Hauwermeiren, the CEO, is actively engaging with investors.
  • The presentation highlights argenx's commitment to advancing in immunology.
  • The availability of a live webcast increases transparency and accessibility.

Full Press Release Details

Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Tim Van Hauwermeiren, Chief Executive Officer, will present at the TD Cowen 45th Annual Healthcare Conference on Monday, March 3, 2025 at 11:50 a.m. ET.
A live webcast of the presentation may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately 30 days following the presentation.

Frequently Asked Questions

When will argenx present at the TD Cowen Conference?

Argentx will present on March 3, 2025, at 11:50 a.m. ET.

Who is the CEO of argenx?

Tim Van Hauwermeiren is the CEO of argenx.

Where can I watch the live webcast?

The live webcast will be available on the Investors section of argenx's website.

How long will the webcast replay be available?

The replay will be accessible for approximately 30 days.

Last updated: Feb 25, 2025